The results of the flow cytometry assay revealed that GRP78-CM treatment relieved the inhibition of 5-FU on CRC cells and significantly reduced the apoptosis rate of CRC cells (Fig. 1F, G). The gene discussed is HSPA5; the disease is colorectal carcinoma.